Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant
The main limitation is absorption
Whether used for BPC-157 for tendon healing, BPC-157 for muscle repair, or BPC-157 for gut healing, patients report noticeable improvements and enhanced recovery outcomes
They are not for human consumption, medical, or veterinary use
The demand for peptides like BPC-157 has increased due to the limited supply of traditional pharmaceutical versions of similar drugs, such as GLP1s, which has led some people to seek alternative sources, including online pharmacies or pharmacies in other countries like Mexico 8m50s
Dose Range: 200600 mcg, using a gradual step-up approach